- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASCO President Dr Peter Yu Discusses Aggregating Patient, Doctor Data
The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president.
The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president and director of cancer research at the Palo Alto Medical Foundation.
Dr Yu will serve as a keynote speaker for The American Journal of Managed Care's 3rd annual "Patient-Centered Oncology Care" meeting on November 13-14 in Baltimore, MD
He outlined the use of ASCO’s health IT platform, CancerLinQ, which will collect data across hundreds of providers and thousands of patients and avoid the bias that can be present in small sample sizes.
“CancerLinQ will allow us to amass this data, aggregate it and analyze it, and then learn from that,” Dr Yu explained. “If that is then married to clinical decision support, so that information is returned to the doctor at the point of care, it will allow the physician to more rapidly consider choices and make better treatment decisions.”
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
